Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
23.30B | 23.65B | 23.97B | 24.34B | 26.27B | 31.10B | Gross Profit |
12.67B | 13.70B | 13.49B | 14.35B | 15.50B | 18.94B | EBIT |
2.54B | 3.92B | 2.68B | 5.70B | 7.45B | 11.29B | EBITDA |
2.54B | 4.74B | 2.43B | 5.85B | 7.71B | 11.41B | Net Income Common Stockholders |
1.35B | 1.65B | 1.29B | 1.34B | 5.19B | 6.34B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
34.33B | 28.38B | 30.96B | 34.07B | 25.72B | 30.99B | Total Assets |
52.10B | 54.63B | 52.04B | 53.16B | 46.08B | 46.05B | Total Debt |
7.10B | 6.10B | 7.10B | 10.20B | 4.21B | 5.31B | Net Debt |
-27.23B | -22.28B | -23.86B | -23.87B | -21.52B | -22.68B | Total Liabilities |
12.08B | 13.18B | 11.83B | 14.41B | 7.84B | 10.28B | Stockholders Equity |
40.00B | 41.44B | 40.19B | 38.73B | 38.23B | 35.77B |
Cash Flow | Free Cash Flow | ||||
0.00 | 3.80B | -325.00M | 4.63B | 3.90B | 9.93B | Operating Cash Flow |
0.00 | 3.87B | -84.00M | 5.05B | 4.79B | 10.01B | Investing Cash Flow |
0.00 | -1.47B | -77.00M | 1.19B | -3.01B | -4.77B | Financing Cash Flow |
0.00 | -2.14B | -3.23B | 4.94B | -4.19B | -3.53B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | ¥40.70B | 75.45 | ― | -18.69% | -48.21% | ||
68 Neutral | ¥11.54B | 21.40 | 1.78% | -21.03% | -42.64% | ||
64 Neutral | ¥42.52B | 25.83 | 3.73% | -1.33% | 5.97% | ||
61 Neutral | $14.56B | 5.82 | -4.02% | 6.41% | 2.72% | -31.67% | |
52 Neutral | ¥12.19B | 33.16 | ― | <0.01% | ― | ||
48 Neutral | ¥34.79B | 17.12 | ― | -12.61% | -314.92% |